Tatva Chintan Pharma Chem Limited (TATVA.BO)
BSE · INR · Basic Materials · Specialty Chemicals
₹1,605.55 (+2.05%) as of
Key statistics
- Market cap
- 37.56B
- P/E (TTM)
- 59.69
- Forward P/E
- 39.19
- EPS (TTM)
- 26.90
- Dividend yield
- 0.13%
- 52-week range
- 1,045.70 – 2,109.95
- Beta
- 0.30
- Revenue (TTM)
- 6.5B
- Profit margin
- 9.68%
- Analyst target
- ₹1,550.00
- Volume
- 5.26k
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, consumer electronics, pharmaceutical, agrochemicals, paints and coatings, dyes, and personal care sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Headquarters
- Vadodara, India
- Employees
- 793
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- SERVICE CARE LIMITED (SERVICE-SM.NS)
- Brookfield India Real Estate T (BIRET.BO)
- Ganesh Consumer Products Limit (GANESHCP.BO)
- CAPITALNUMBERS INFOTECH LIMIT (CNINFOTECH.BO)
- Motilal Oswal Mutual Fund-Perm (MOMENTUM50.BO)
- BIRLASLAMC - HEALTHY (HEALTHY.NS)
- ArisInfra Solutions Limited (ARIS.BO)
- BRIGHT BROTHERS LTD. (BRIGHTBR.BO)